Belvedere Trading »

Karyopharm Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $99k 15k 6.54

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Strategy Cl A New (MSTR)
Apple (AAPL)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Palantir Technologies Cl A (PLTR)

View all positions for Belvedere Trading

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Adage Capital Partners GP
Vanguard Group
Susquehanna International
BlackRock
Affinity Asset Advisors
Catalio Capital Management
Avidity Partners Management
Marshall Wace
CAM Group Holding A/S
Geode Capital Management
Citadel Advisors
Group One Trading
Renaissance Technologies
UBS Group

View all funds holding Karyopharm Therapeutics